Thiogenesis Therapeutics Corp's total assets for Q4 2023 were $5.69M, a decrease of -21.47% from the previous quarter. TSE:TTI total liabilities were $344.60K for the fiscal quarter, a -79.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.